EPM
BSX icon

Equitec Proprietary Markets’s Boston Scientific BSX Stock Holding History

Equitec Proprietary Markets’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Buy
+11,100
New +$888K 0.37% 31
2015
Q1 		– Sell
-11,975
Closed -$159K – 207
2014
Q4 		$159K Buy
+11,975
New +$153K 0.01% 360

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Equitec Proprietary Markets's BSX Position: Q1 2026 in Review

Equitec Proprietary Markets opened a new position in Boston Scientific (BSX) in Q1 2026: 11,100 shares worth $697K. The stake represents 0.37% of the portfolio and ranks #31 among its holdings. This is a return to the name: Equitec Proprietary Markets previously reported a position in BSX as recently as Q4 2014.

Equitec Proprietary Markets first reported a position in BSX in Q4 2014 and has held it in 2 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Equitec Proprietary Markets held 11,100 shares of Boston Scientific worth $697K as of Q1 2026.
  • Boston Scientific was a new Equitec Proprietary Markets position in Q1 2026.
  • Boston Scientific made up 0.37% of Equitec Proprietary Markets's portfolio in Q1 2026, its #31 holding.
  • Equitec Proprietary Markets first reported a position in Boston Scientific in Q4 2014 and has held it in 2 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Equitec Proprietary Markets's 13F filing for Q1 2026, filed 11 May 2026.